These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11235927)

  • 1. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.
    Andrade C; Srihari BS; Reddy KP; Chandramma L
    J Clin Psychiatry; 2001 Jan; 62(1):41-5. PubMed ID: 11235927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study.
    Suresh Kumar PN; Andrade C; Bhakta SG; Singh NM
    J Clin Psychiatry; 2007 Feb; 68(2):237-41. PubMed ID: 17335321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Melatonin--a natural hypnotic?].
    Saletu B
    Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.
    Wyatt JK; Dijk DJ; Ritz-de Cecco A; Ronda JM; Czeisler CA
    Sleep; 2006 May; 29(5):609-18. PubMed ID: 16774150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT.
    van Geijlswijk IM; van der Heijden KB; Egberts AC; Korzilius HP; Smits MG
    Psychopharmacology (Berl); 2010 Oct; 212(3):379-91. PubMed ID: 20668840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temazepam or Melatonin Versus Placebo for the Treatment of Insomnia in Advanced Cancer: A Three-Arm, Double-Blind, Phase III, Multicenter, Randomized Clinical Trial.
    Mendis R; Wong A; Frenkel S; Southcott AM; Selman CJ; Martin J; Grobler A; Currow D; Agar M; Le B; Philip J
    J Palliat Med; 2024 Oct; 27(10):1368-1373. PubMed ID: 39304187
    [No Abstract]   [Full Text] [Related]  

  • 10. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
    Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M; Niskanen L; Kangas AP; Koskinen T
    Nord J Psychiatry; 2005; 59(3):217-21. PubMed ID: 16195124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
    Shaw SH; Curson H; Coquelin JP
    J Int Med Res; 1992 Apr; 20(2):150-61. PubMed ID: 1521671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of melatonin as a hypnotic agent.
    Mendelson WB
    J Biol Rhythms; 1997 Dec; 12(6):651-6. PubMed ID: 9406041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
    J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study.
    MacFarlane JG; Cleghorn JM; Brown GM; Streiner DL
    Biol Psychiatry; 1991 Aug; 30(4):371-6. PubMed ID: 1912128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
    Eckerberg B; Lowden A; Nagai R; Akerstedt T
    Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
    J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.